Latest "irbesartan amlodipine irbesartan Hypertension" News Stories

23:13 EST 21st December 2014 | BioPortfolio

Here are the most relevant search results for "irbesartan amlodipine irbesartan Hypertension" found in our extensive news archives from over 250 global news sources.

More Information about irbesartan amlodipine irbesartan Hypertension on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about irbesartan amlodipine irbesartan Hypertension for you to read. Along with our medical data and news we also list irbesartan amlodipine irbesartan Hypertension Clinical Trials, which are updated daily. BioPortfolio also has a large database of irbesartan amlodipine irbesartan Hypertension Companies for you to search.

Showing "irbesartan amlodipine irbesartan Hypertension" News Articles 1–25 of 940

Extremely Relevant

Human medicines European public assessment report (EPAR): Irbesartan Zentiva (previously Irbesartan Winthrop), irbesartan, Revision: 15, Authorised

Human medicines European public assessment report (EPAR): Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop), irbesartan / hydrochlorothiazide, Revision: 19, Authorised

Human medicines European public assessment report (EPAR): Irbesartan Teva, irbesartan, Revision: 6, Authorised

Human medicines European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka), irbesartan, Revision: 5, Authorised

Human medicines European public assessment report (EPAR): Irbesartan/Hydrochlorothiazide Teva, irbesartan / hydrochlorothiazide, Revision: 7, Authorised

Human medicines European public assessment report (EPAR): Sabervel, irbesartan, Revision: 2, Authorised

Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Revision: 32, Authorised

Human medicines European public assessment report (EPAR): Karvea, irbesartan, Revision: 31, Authorised

Human medicines European public assessment report (EPAR): Ifirmacombi, irbesartan / hydrochlorothiazide, Revision: 2, Authorised

Human medicines European public assessment report (EPAR): CoAprovel, irbesartan / hydrochlorothiazide, Revision: 30, Authorised

Human medicines European public assessment report (EPAR): Karvezide, irbesartan / hydrochlorothiazide, Revision: 31, Authorised

Relevant

Par Pharmaceutical Begins Shipment of Generic Exforge®

WOODCLIFF LAKE, N.J., Sept. 30, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has begun shipping all four strengths of amlodipine and valsartan tablets, the generic version of Novartis' Exforge®.  Par received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for amlodipine and valsartan and was grant...

Simultaneous Determination of Amlodipine and Its Counterion Besylate

Thermo Fisher Scientific has developed a simple, rapid, reliable, and accurate high-performance liquid chromatography (HPLC) method for the simultaneous determination of amlodipine and besylate in an amlodipine besylate drug substance. Application Note 1087: Simultaneous Determination of Amlodipine and Its Counterion Besylate by HPLC demonstrates that this method requires only ...

Transfer of Distribution and Termination of Co-promotion for Caduet® Combination Tablets

Pfizer Japan Inc. (Tokyo, “Pfizer”) and Astellas Pharma Inc. (Tokyo: 4503, “Astellas”) today announced that the companies have agreed to terminate the distribution and co-promotion agreement in Japan for a combination drug o...

Attitudes and preferences for the clinical management of hypertension and hypertension-related cardiac disease in general practice: results of the Italian Hypertension and Heart Survey

Interventional Management in Hypertension

What types of device-based interventions to lower drug-resistant hypertension have been developed over the last number of years, and how effective are they? Current Opinion in Nephrology and Hypertension

Hypertension: Fluid overload and post-dialysis hypertension

Although intradialytic hypertension is associated with all-cause mortality, the mechanisms that underlie this phenomenon are not well understood. Now, Nongnuch et al. report that post-dialysis hypertension is associated with extracellular fluid over...

Hypertension, Lengthy Beta-Blocker Use May Provoke Psoriasis

In a prospective cohort study of women in their 60s, long-term use of beta-blockers for hypertension, and hypertension itself, were linked with a higher risk of developing psoriasis. Heartwire

Undiagnosed hypertension more likely in rheumatoid arthritis

(HealthDay)—Among patients meeting guideline-based criteria for hypertension, those with rheumatoid arthritis (RA) are less likely to receive a diagnosis of hypertension, according to a study published in the September issue of Arthritis Care & Res...

Hypertension Partnering 2009-2014

Recently added to the BioPortfolio report store, Hypertension Partnering 2009-2014 is a new report from Current Partnering published on 2014-10-31. This 100+-page report is available from $995. The Hypertension Partnering 2009-2014 report provides understanding and access to the hypertension partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in hypert...

Causal link between vitamin D deficiency, hypertension suggested by researchers

New genetic research provides compelling evidence that low levels of vitamin D have a causal role in the development of high blood pressure (hypertension). The findings suggest that vitamin D supplementation could be effective in combating some cases...

Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease

Silver Spring, Md. (PRWEB) August 21, 2014 Pulmonary Hypertension Association goes on the road to Houston with an Education Forum for PH patients and families to help fight rare lung disease. Who:    The Pulmonary Hypertens...

Pediatric Hypertension

Read this to learn about pharmacologic and lifestyle management for hypertension in children. U.S. Pharmacist

Genetic study suggests causal link between vitamin D deficiency and hypertension

New genetic research provides compelling evidence that low levels of vitamin D have a causal role in the development of high blood pressure (hypertension). The findings, published in The Lancet Diabetes & Endocrinology, suggest that vitamin D supplem...

Decade in review—hypertension: The past decade in hypertension—facts, hopes, and hypes

Hypertension research in the past decade has been a mixture of hope and hype. In the absence of new drug developments, clinical intervention procedures such as renal nerve ablation and baroreflex activation therapy have dominated the research, but th...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks